INSTITUT CATALA DE LA SALUT - Spain 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:900-1000
Total Number of Projects:500-600
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:500-600
Total Number of Projects:66
Total Project Funding:300-400
Networking Rank (Reputation):300-400
Networking Rank (Reputation):300-400
Partner Constancy:46
Project Leadership Index:71
Diversity Index:60
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:800-900
Project Leadership Index:800-900
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):900-1000
Partner Constancy:900-1000
Project Leadership Index:900-1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
Total Project Funding:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:500-600
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 29
As coordinator: 1
As participant: 28
Sole participant: 0
Coordinator / Participant Ratio: 0.04*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 39.345.552 2.120.008 6
2018 0 14.994.579 2.352.046 3
2016 0 6.916.081 302.447 1
2015 0 5.938.573 610.000 2
2014 0 5.999.995 155.080 1
2013 0 15.250.060 811.093 3
2012 2.998.217 31.894.000 2.641.264 1 5
2011 0 21.964.910 528.416 4
2010 0 29.023.701 1.326.446 3

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITY COLLEGE LONDON8
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS6
CHARITE UNIVERSITAETSMEDIZIN BERLIN6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
KING'S COLLEGE LONDON5
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE4
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT4
KATHOLIEKE UNIVERSITEIT LEUVEN4
MEDIZINISCHE UNIVERSITAET WIEN4
REGION HOVEDSTADEN4
SERVICIO MADRILENO DE SALUD4
UNIVERSITA DEGLI STUDI DI TORINO4
UNIVERSITY OF GLASGOW4
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM3
ACADEMISCH ZIEKENHUIS GRONINGEN3
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA3
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA3
UNIVERSITA DEGLI STUDI DI PADOVA3
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA3
UNIVERSITAETSKLINIKUM HEIDELBERG3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
BCN PEPTIDES2
CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA EPE2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONCENTRIS RESEARCH MANAGEMENT2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EURAM LIMITED2
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER2
EUROPEAN LIVER PATIENTS ASSOCIATION2
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL2
FUNDACAO OSWALDO CRUZ2
GENESIS BIOMED2
HOSPITAL CLINIC DE BARCELONA2
INSERM TRANSFERT2
INSTITUT KLINICKE A EXPERIMENTALNI MEDICINY2
INSTITUTE OF PSYCHIATRY AND NEUROLOGY2
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI2
LEIDEN UNIVERSITY MEDICAL CENTER2
LIVERPOOL JOHN MOORES UNIVERSITY2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
OSPEDALE SAN RAFFAELE2
REGION STOCKHOLM2
SEMMELWEIS EGYETEM2
SEMMELWEIS UNIVERSITY OF MEDICINE2
SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH2
SYDDANSK UNIVERSITET2
TECHNISCHE UNIVERSITAET DRESDEN2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE UNIVERSITY OF NOTTINGHAM2
UNIVERSITAET DES SAARLANDES2
UNIVERSITAET LEIPZIG2
UNIVERSITAETSKLINIKUM AACHEN2
UNIVERSITAIR ZIEKENHUIS ANTWERPEN2
UNIVERSITAT DE BARCELONA2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITE DE GENEVE2
UNIVERSITEIT MAASTRICHT2
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN2
UNIVERSITY OF AARHUS2
UNIVERSITY OF BERGEN2
UNIVERSITY OF NEWCASTLE UPON TYNE2
3P BIOPHARMACEUTICALS SL1
ABBVIE INC1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACCELOPMENT DEUTSCHLAND1
ACCELOPMENT SCHWEIZ1
ADMINISTRACION NACIONAL DE LABORATORIOS E INSTITUTOS DE SALUD DR CARLOS G MALBRAN1
AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA1
AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM1
AIBILII ASSOCIACAO DE APOIOAO INSTITUTO BIOMEDICO DE INVESTIGACAO DA LUZ E IMAGEM1
AINTREE UNIVERSITY HOSPITAL NHS FOUNDATION TRUST1
ALB FILS KLINIKEN1
ALMAC DIAGNOSTICS LIMITED1
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
ALZHEIMER EUROPE1
AMGEN1
ANAXOMICS BIOTECH S L1
APPATWORK1
ASTELLAS PHARMA EUROPE B V1
ASTON UNIVERSITY1
AVANTEA1
AZIENDA OSPEDALEUNIVERSITA PADOVA1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO1
AZIENDA OSPEDALIERA DI PADOVA1
AZIENDA OSPEDALIEROUNIVERSITARIA MAGGIORE DELLA CARITA NOVARA1
BARCELONA SUPERCOMPUTING CENTERCENTRO NACIONAL DE SUPERCOMPUTACION1
BAYLOR COLLEGE OF MEDICINE CORPORATION BCM1
BEIJING GENOMICS INSTITUTE AT SHENZHEN1
BENGURION UNIVERSITY OF THE NEGEV1
BIOCRATES LIFE SCIENCES1
BIOGAZELLE1
BIOLUTION1
BIONTECH1
BIOTRIAL1
BMJ PUBLISHING GROUP LIMITED1
BRAHMS1
BRISTOL MYERS SQUIBB INTERNATIONAL CORPORATION1

Constancy:

Total number of partners: 477
Partner loyalty:
Frequent Partner: (> 2 projects): 97
Rare Partner: 380
Frequent / Rare Partner Ratio: 0.26

Project overview:

Start dateProjectacronymrolefundingpartners
2020-12-01Intelligent plug-and-play digital tool for real-time surveillance of COVID-19 patients and smart decision-making in Intensive Care Units ENVISIONparticipant4.874.11121
2020-10-01H2O Health Outcomes Observatory H2Oparticipant10.476.68723
2020-04-01DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES DECISIONparticipant6.000.00025
2020-01-01Prevention and Remediation of Insulin Multimorbidity in Europe PRIMEparticipant6.000.00018
2020-01-01Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia RECOGNISEDparticipant5.998.27325
2020-01-01Screening for liver fibrosis - population-based study across European countries LiverScreenparticipant5.996.48123
2018-12-01Platform for Innovation of Procurement and Procurement of Innovation PIPPIparticipant2.996.0008
2018-01-01NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION RESTOREparticipant5.357.0338
2018-01-01The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients EU-TRAINparticipant6.641.54613
2016-10-01ZIKAction: Preparedness, research and action network on maternal-paediatric axis of ZIKV infection in Latin America and the Caribbean ZIKActionparticipant6.916.08114
2015-05-01Screening for Chronic Kidney Disease (CKD) among Older People across Europe (SCOPE) SCOPEparticipant2.950.0009
2015-01-01Scalable, point-of-care and label free microarray platform for rapid detection of Sepsis RAISparticipant2.988.5739
2014-02-01Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies DISCHARGEparticipant5.999.99528
2013-09-01Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves TRANSLINKparticipant5.996.97113
2013-09-01Development of a universal influenza vaccine based on tandem core technology FLUTCOREparticipant3.872.9197
2013-01-01Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action EUROFANCOLENparticipant5.380.17011
2012-11-01Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation BIO-DRIMparticipant5.989.00017
2012-11-01Glioma Actively Personalized Vaccine Consortium GAPVACparticipant5.970.43613
2012-09-01Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE BERENICEcoordinator2.998.2178
2012-03-01European Consortium for the Early Treatment of Diabetic Retinopathy EUROCONDORparticipant5.998.76218
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01Pathways common to brain development and ageing: defining strategies for preventive therapy and diagnostics DEVELAGEparticipant2.994.1379
2011-11-01The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction BAMIparticipant5.993.08322
2011-04-01Addictions and Lifestyles In Contemporary Europe – Reframing Addictions Project ALICE RAPparticipant7.978.22645
2011-04-01Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE ARTFORCEparticipant5.994.71514
2011-02-01International Human Microbiome Standards IHMSparticipant1.998.8868
2010-12-01Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation MABSOTparticipant5.929.06410
2010-04-01CARDIO REPAIR EUROPEAN MULTIDISCIPLINARY INITIATIVE CARE-MIparticipant11.305.10320
2010-01-01Systems biology towards novel chronic kidney disease diagnosis and treatment SysKIDparticipant11.789.53429